Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM update

9 Oct 2014 07:00

RNS Number : 8125T
Polar Capital Holdings PLC
09 October 2014
 



09 October 2014

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital is pleased to report a further increase in its AUM over the six month period through to the end of September 2014 to $13.4bn, an increase of 1% over the $13.2bn reported at 31 March 2014 and an increase of over 17% from the $11.4bn reported at September 2013.

 

The table below sets out the movements in the Group's AUM over the six month period:

 

AUM movement

Six months to 30 September 2014

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2014

$12,315m

$934m

$13,249m

Net subscriptions / (redemptions)

$(425)m

$117m

$(308)m

Closure of EMN team

nil

$(67)m

$(67)m

Market movement and performance

$549m

$(1)m

$548m

Total AUM at 30 September 2014

$12,439m

$983m

$13,422m

 

Comment

 

There remains considerable uncertainty over the direction of the Japanese equity market and this has resulted in material outflows from our Japan UCITS fund over the last two quarters following the exceptional growth we had experienced in previous years. However, strong inflows into a number of our other products over the September quarter and a general improvement in markets since 31 March 2014 have allowed us to increase assets once again over the latest six month period.

 

At the end of the period we were delighted to announce the arrival of two new teams into the Polar stable, namely Guy Rushton (from Legal & General) heading up a UK Absolute Equity team and Nick Davis (from Threadneedle) heading up a European Income franchise. A UCITS product has already been launched for Guy and it is anticipated that early in the next quarter a UCITS sub fund will be launched for Nick.

 

We have been consistent in signalling our short term caution regarding the AUM growth of the Group given the uncertainty in the outlook for the Japanese market. Nevertheless, we believe over the medium term the Group is well placed to grow assets further, given we have a number of products that have considerable scope for more capacity and assuming no meaningful deterioration in the overall outlook for global equity markets.

 

 

 

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first six months of the Group's financial year. The majority of the Group's performance fees crystallise in the second half of the financial year.

 

Performance fees

net of staff allocations

Six months to

30 Sept 13

£m

Year to

31 Mar 14

(year-end)

£m

Six months to

30 Sept 14

£m

Received

£0.0m

£7.6m

£0.0m

Accrued but not yet earned in funds with year ends on or before the financial year end

£4.5m

n/a

£4.2m

Total net performance fees

£4.5m

£7.6m

£4.2m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)

John Mansell (CFO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Cameron Duncan

+44 (0)20 7523 8000

 

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALEPESLLFFF
Date   Source Headline
4th Feb 20199:43 amRNSBlock listing Interim Review
1st Feb 201911:41 amRNSTotal Voting Rights
29th Jan 20194:41 pmRNSSecond Price Monitoring Extn
29th Jan 20194:35 pmRNSPrice Monitoring Extension
28th Jan 20195:45 pmRNSIssue of Equity
28th Jan 20195:30 pmRNSDirector/PDMR Shareholding
10th Jan 201910:19 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSAUM Update
2nd Jan 20199:49 amRNSTotal Voting Rights
12th Dec 20184:00 pmRNSIssue of Equity
27th Nov 20184:40 pmRNSSecond Price Monitoring Extn
27th Nov 20184:35 pmRNSPrice Monitoring Extension
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.